Institution
Baycrest Academy for Research and Education
Also known as: Baycrest Health Sciences · BARE
- 6running trials
- 3closed trials
- 1,535publications (OpenAlex)
Running trials
Recruiting
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Recruiting
SYNERGIC-2 Trial (SYNchronizing, Exercises and Remedies to GaIn Cognition@Home)
Recruiting
Recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease3 recruiting
- Mild cognitive impairment2 recruiting
Closed trials
Terminated
Completed
Terminated
Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients
Registry name variants (2)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Baycrest Health Sciences
Toronto, M6A 2E1
8 trials
Baycrest Academy for Research and Education
Toronto, Ontario
1 trial
NCT05375513SYNERGIC-2 Trial (SYNchronizing, Exercises and Remedies to GaIn Cognition@Home)
Contact: Dr. Howard Chertkow
Conditions
Diseases this institution publishes on or runs trials for.
- Mild cognitive impairment30 works · 2 trials
Institution data: ROR 001fxzj49 (CC0-1.0)Updated 15 Nov 2026